50 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
stock and consider available options depending on the trading price of our common stock, no assurance can be made that we will in fact be able to comply … conditions and the market perception of our business may adversely affect the market price of our common stock. As a result, there can be no assurance
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
, and your Replacement Options may become underwater after the Offer Expiration Date. WE CAN PROVIDE NO ASSURANCE AS TO THE PRICE OF SHARES OF OUR COMMON STOCK
SC TO-I
EX-99
rewugfkvx34cb6cws
30 Jan 24
Issuer tender offer statement
7:04am
424B3
wfa785 5k8o1n97
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
7yt5hwoj08rx4s
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
ckvyne8z
7 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm